Wordt geladen...
QbD Based Media Development for the Production of Fab Fragments in E. coli
Ranibizumab is a biotherapeutic Fab fragment used for the treatment of age-related macular degeneration and macular oedema. It is currently expressed in the gram-negative bacterium, Escherichia coli. However, low expression levels result in a high manufacturing cost. The protein expression can be in...
Bewaard in:
| Gepubliceerd in: | Bioengineering (Basel) |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6631317/ https://ncbi.nlm.nih.gov/pubmed/30925730 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/bioengineering6020029 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|